SAN JOSE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced a strategic partnership with The Glimpse Group, Inc., a spatial computing, AI and Immersive technology platform company (NASDAQ: VRAR), to expand access to healthcare career pathways through the launch of the Medical Assisting Skills Virtual Trainer. The new software application empowers students to practice 33 essential clinical and administ ...

LA JOLLA, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Private Bancorp of America, Inc. (OTCQX:PBAM), (“Company”) and CalPrivate Bank (“Bank”) announced today the appointment of Kathy Moe Lonowski to the board of its subsidiary, CalPrivate Bank. Ms. Lonowski brings a wealth of experience from her distinguished career in financial services, regulatory compliance, risk management, and governance, making her an invaluable asset to the Bank’s strategic leadership. Ms. Lonowski is an accomplished financial industr ...

VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Blast Resources Inc. (“Blast” or the “Company”) (CSE: BLST | FSE: O0E) is pleased to announce that it has contracted Mr. Steven R. McMullen to complete a Technical Report (the “Report”) in accordance with National Instrument 43-101 on its 100% owned Wales Lake South Project (“Project”) located in the highly prospective southwestern Athabasca Basin region of northern Saskatchewan, Canada. Mr. McMullan has world-wide experience in mineral explora ...

Management’s presentation will take place on Wednesday, September 3rd, 2025 at 1:30 pm (ET)DURHAM, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel, CFO, will participate in the Wells Fargo Healthcare Conference. Management’s presentation will take place on Wednes ...

Enhancing Wellhead to Water StrategyHOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, “Plains”) announced today that a wholly owned subsidiary has entered into a definitive agreement to acquire from subsidiaries of Diamondback Energy, Inc. and Kinetik Holdings Inc., a 55% non-operated interest in EPIC Crude Holdings, LP (“EPIC Crude Holdings”), the entity that owns and operates the EPIC Crude Oil Pipeline (“EPIC ...

Core Insights - Eupraxia Pharmaceuticals announced positive clinical data from its Phase 1b/2a RESOLVE trial for EP-104GI, a treatment for eosinophilic esophagitis (EoE), showing promising results at 52 weeks post-treatment [1][2]. Clinical Trial Results - The RESOLVE trial demonstrated that patients receiving 4mg of EP-104GI showed clinical remission rates of 56% at Week 12, 78% at Week 24, 67% at Week 36, and 67% at Week 52 [3]. - Two-thirds of patients in the 48mg dose cohort maintained clinical remission after 12 months, indicating durable treatment effects [7]. - Improvements in tissue health were observed across all cohorts, with significant reductions in EoE Histological Scoring System (EoEHSS) scores, showing a 47% improvement in severity and a 44% improvement in extent at Week 36 [8]. Pharmacokinetics - Plasma levels of fluticasone in patients treated with 4mg of EP-104GI remained stable and predictable over 52 weeks, significantly lower than levels typically seen with daily asthma inhalers [9][11]. Market Potential - The treatment regimen for EP-104GI could align with the annual endoscopy routine for EoE patients, contrasting with current treatments that require daily or weekly administration [2]. - EoE affects over 450,000 individuals in the U.S., with increasing incidence and prevalence, highlighting a significant market opportunity for effective treatments [17]. Company Overview - Eupraxia Pharmaceuticals focuses on developing locally delivered, extended-release products targeting high unmet medical needs, utilizing its proprietary Diffusphere™ technology for optimized drug delivery [18][19].

Experienced legal leader brings deep expertise in governance, strategic transactions, and risk management to support Vor Bio’s growthCAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. “We are delighte ...

BEIJING, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the “Company”) today announced that it will implement a reverse stock split of its ordinary shares at a ratio of five (5) to one (1), The Company’s ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market at that time under the same ticker symbol, TIRX, effective at the open of business on September 5, 2025. As part of the reverse stock split, the par value of the Company’s Class A and Cl ...

GREENWICH, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (the “Company”) reported that it expects to implement the previously announced 1-for-5 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share (“Common Stock”), effective as of September 5, 2025, with trading to begin on a split-adjusted basis at market open on the following business day, September 8, 2025. As a result of the reverse stock split, every five shares of Co ...

LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), today announces the signing of a Joint Venture with Kayanat, a family office in the Kingdom of Saudi Arabia (KSA), with the intention to transform the country’s estimated $60Bn1 market for Fast Moving Consumer Goods (FMCG). The partnership aligns with Saudi Arabia’s Vision 2030 economic transformation goals, using smart AI-powered trading technology within the RedAI platform to unlock efficient digi ...